Immunotherapy for non-small cell lung cancer in the elderly population: a generic protocol

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the effectiveness and safety of immune checkpoint inhibitors (ICI) as monotherapy or in combination (with chemotherapy or immunotherapy) compared to chemotherapy for elderly people (≥ 65 years) with non-small cell lung cancer (NSCLC). 

This is a protocol.